Caffeine Toxicity

Earn CME/CE in your profession:


Continuing Education Activity

Caffeine toxicity arises from the excessive consumption of caffeine, a widely used stimulant recognized for enhancing mental alertness. With 85% of Americans consuming caffeine daily and an average cup of coffee containing 40 to 150 mg of caffeine, the risk of toxicity increases with inadvertent overuse or intentional overdose. Caffeine is present in various over-the-counter products, including energy drinks, appetite suppressants, stimulants, exercise supplements, decongestants, bronchodilators, and mental stimulants, making unintentional overexposure common.[1][37]

This activity reviews the pathophysiology of caffeine toxicity, including its clinical manifestations and diagnostic approaches. Management strategies, including supportive care and targeted interventions, are discussed to address mild, moderate, and severe cases. Emphasis is placed on the role of the interprofessional team in preventing, identifying, and managing caffeine toxicity to improve patient outcomes. Understanding the diverse sources of caffeine and their potential interactions aids healthcare providers in mitigating risks associated with overuse.

Objectives:

  • Identify the pathophysiology of caffeine toxicity.

  • Assess the signs and symptoms of caffeine toxicity.

  • Implement appropriate management strategies, including supportive care, activated charcoal, or hemodialysis, for caffeine toxicity.

  • Apply interprofessional team strategies to improve care coordination and communication, advance the treatment of caffeine toxicity, and improve outcomes.

Introduction

Caffeine is a stimulant that has been used globally for centuries due to its ability to improve mental alertness. Approximately 85% of Americans consume caffeine daily, with an average cup of coffee containing between 40 and 150 mg of caffeine.[1] Caffeine can be found in various over-the-counter products, such as energy drinks, appetite suppressants, stimulants, exercise supplements, decongestants, bronchodilators, and mental stimulants, increasing the risk of toxicity with inadvertent overuse or severe toxicity with an intentional overdose.[2][3]

Lethal doses of caffeine have been reported at blood concentrations of 80 to 100 μg/mL, which can result from ingesting approximately 10 g or more of caffeine.[4][5][6][7][8]

Etiology

Lethal overdoses of caffeine in adults are rare and are commonly caused by an intentional overdose of medications.[9][10][11] Conversely, caffeine toxicity in children is typically caused by accidental ingestion.[12] Toxic ingestions can occur after consuming energy drinks but are rarely observed in patients who have consumed coffee or tea, secondary to the excessive amount of fluid required to reach toxic levels.[13]

Over-the-counter products containing large doses of caffeine purchased for their stimulant properties can also contribute to caffeine toxicity. These products include health food items, diet aids, decongestants, bronchodilators, and stay-awake pills.[14]

Epidemiology

Each year, Poison Control Centers in the United States receive over 3000 reports of caffeine-related exposures, with pediatric and adult cases occurring at an equal ratio. On average, less than 2 of these reports typically end in fatality.[15]

Pathophysiology

As caffeine can affect a variety of different receptors, the adverse effects of caffeine overdose can be profound. Caffeine is a natural alkaloid methylxanthine that acts as a nonselective antagonist of adenosine receptors, with A1 antagonism triggering seizures and A2 antagonism triggering cerebral and coronary vasoconstriction. In addition, caffeine inhibits phosphodiesterase, increasing intracellular cyclic AMP and intracellular calcium levels. Caffeine can stimulate the release of catecholamines, especially noradrenaline, with β1 agonist activity resulting in tachycardia and β2 agonist activity resulting in peripheral vasodilation and hypotension.[5][11][16][17] Caffeine also sensitizes dopamine receptors and is a competitive antagonist of benzodiazepine receptors. Furthermore, caffeine increases renin excretion, resulting in initial hypertension, sodium retention, and water retention.[7][11][18][19]

Toxicokinetics

Caffeine is rapidly and nearly completely absorbed by the stomach (up to 90%), with peak plasma concentrations occurring within 20 to 40 min.[20] As a result, toxic levels can be reached quickly and last for prolonged periods, secondary to caffeine's half-life of 3 to 10 h. The liver metabolizes caffeine through N-demethylation, acetylation, and oxidation. Other substances that use the same pathways, such as alcohol or medications, can prolong the half-life of caffeine by approximately 72%.[7][10]

History and Physical

Physical examination findings characteristic of caffeine toxicity include nausea, vomiting, tachycardia, tachypnea, depressed consciousness, irritability, headache, and early-stage hypertension, followed by hypotension. Pupils may demonstrate mydriasis. Muscles may be rigid, and deep tendon reflexes may be accentuated (hyperreflexia). A neurological examination may reveal altered mentation, agitation, delusional thoughts, hallucinations, seizures, or even focal neurological findings thought to be due to ischemia from vasoconstriction. Nausea is the most common symptom, and vomiting is also frequently reported.[18][21][22]

Evaluation

Routine serum laboratory evaluations can be useful in drug overdose cases, especially in patients with unstable vital signs, seizures, or altered sensorium. Serum caffeine levels can guide prognosis and therapy. Although not available in all hospitals, serum caffeine levels are generally measured using an immunoassay.[23][24] Lethal blood levels are typically above 80 to 100 mg/L, although ingestions of 5 to 50 g have resulted in fatalities.[7][9][19][25]

Venous blood gas testing may reveal anion gap metabolic acidosis, which can be severe. Lactate levels are commonly elevated.[5] Caffeine toxicity can result in hypokalemia, hypocalcemia, hyponatremia, and hyperglycemia. Clinicians should also obtain serum myoglobin and creatine kinase levels to monitor for rhabdomyolysis. An electrocardiogram may show tachycardia, ST-segment depressions, or T-wave inversions. Cardiac monitoring allows the evaluation of heart rate and the early recognition of dysrhythmias, such as ventricular ectopy or fibrillation.[11][18][21]

Treatment / Management

Fatal caffeine overdose is relatively rare, and treatment information is limited to case reports. The primary treatment for minor caffeine ingestion is supportive care, including advanced cardiac life support or pediatric advanced life support as needed. Hydration may be oral for minor cases. Patients with severe toxicity benefit from intravenous hydration. Beta-blockers such as esmolol or metoprolol are effective for treating tachycardia. Procainamide, lidocaine, or bicarbonate have also been used to treat tachydysrhythmias.[26] Adenosine and electrical cardioversion in cases of caffeine toxicity have not been shown to have any sustained effect on cardiac dysrhythmias.[27][28] Vasopressors, such as norepinephrine or phenylephrine, can help maintain a goal arterial pressure greater than 65 mm Hg without worsening tachycardia.[17] Activated charcoal can bind caffeine if the ingestion is recent, and repeated doses can help diminish serum levels through enterohepatic circulation. 

Orogastric lavage using a standard nasogastric tube has also been reported to help aspirate caffeine contents, but only if initiated within 1 h of ingestion. If the patient develops symptomatic hypokalemia, then potassium should be replaced. Hemodialysis has been effective in severe, life-threatening caffeine ingestions. The first-line treatment for seizures includes benzodiazepines, such as lorazepam, diazepam, and midazolam. Phenobarbital and propofol may be used to treat refractory seizures. Both phenytoin and fosphenytoin are not recommended for the treatment of seizures related to caffeine toxicity in response to case reports of increased mortality in animal models with methylxanthine toxicity.[29] Caffeine exhibits ideal characteristics for dialysis, including low protein binding (36%), low molecular size (194 kDa), and a small volume of distribution (0.6 to 0.8 L/kg). Dialysis can be discontinued when clinical improvement is observed or when the serum caffeine concentration is less than 15 mg/L.[30] Imminent cardiac arrest in caffeine toxicity should prompt intralipid therapy to scavenge the free serum caffeine.[18][31] Extracorporeal membrane oxygenation can be considered for patients who are resistant to treatment and are hemodynamically unstable.[32][33]

Differential Diagnosis

Caffeine toxicity can present with symptoms similar to those of the following conditions:

  • Amphetamine toxicity
  • Atrial fibrillation/flutter
  • Beta-adrenergic agonist overdose
  • Carbon monoxide toxicity
  • Cathinone toxicity
  • Cocaine toxicity
  • Cyanide toxicity
  • Delirium tremens
  • Diabetic ketoacidosis
  • Disulfiram toxicity
  • Intracranial hemorrhage
  • Iron toxicity
  • Monoamine oxidase inhibitor toxicity
  • Multifocal atrial tachycardia
  • Polysubstance overdose
  • Salicylate toxicity
  • Septic shock
  • Status epilepticus
  • Theophylline toxicity
  • Thyrotoxicosis
  • Ventricular fibrillation
  • Ventricular tachycardia

Prognosis

There are relatively few deaths reported from caffeine overdose; however, the prognosis largely depends on how quickly treatment is implemented.[13] In cases of severe caffeine overdose, the prognosis is directly correlated with the timeliness of caffeine removal from the bloodstream using hemodialysis or intralipid emulsion therapy.[18]

Complications

Complications of caffeine overdose include seizure, neurological changes, tachydysrhythmia, ECG changes, hypokalemia, hyperglycemia, and anion gap metabolic acidosis secondary to lactic acidosis. Severe cases can result in acute kidney injury, rhabdomyolysis, and even cardiac arrest.[8][22]

Postoperative and Rehabilitation Care

Due to the relatively short half-life of caffeine, patients often quickly return to baseline as caffeine levels trend down. Neurological and cardiac changes have been reported to resolve spontaneously as caffeine is excreted from the body. All electrolyte abnormalities should be corrected and are unlikely to reoccur once caffeine levels are normalized.[34]

Consultations

There is no established standard of care or treatment plan for caffeine overdose, but consulting poison control is highly recommended when managing these cases. For severe overdoses requiring hemodialysis, nephrology consultation is necessary.[16][17][19][17][26][30] Cardiology may also need to be consulted for associated dysrhythmias. If an extracorporeal membrane oxygenation team is present, they may need to be consulted for severe cases.[35] These patients likely need to be admitted to the intensive care unit (ICU) and may benefit from consulting critical care.

Deterrence and Patient Education

Caffeine is easily accessible as an over-the-counter medication and component in several products.[2] Patients should be cautioned that caffeine can affect a variety of receptors, and the adverse effects can be profound. Toxic levels can be reached quickly, leading to significant morbidity and mortality if not treated promptly.[7][10]

Pearls and Other Issues

Considerations for caffeine toxicity are as follows:

  • In cases of sympathomimetic toxidrome of unknown cause, clinicians should consider caffeine toxicity, especially in the setting of hypotension, as caffeine levels can be measured, and specific therapy with activated charcoal, hemodialysis, or intralipid can be instituted.
  • Caffeine overdose does not have an established standard of care treatment plan, but toxic serum caffeine levels can be successfully reversed when recognized and treated early.
  • Caffeine is available over the counter and can quickly reach toxic levels when taken in excess.
  • Seizures and cardiac dysrhythmias are commonly observed in toxic caffeine overdose.
  • Esmolol is the first-line treatment for tachydysrhythmias associated with caffeine overdose.

Enhancing Healthcare Team Outcomes

Managing a caffeine overdose requires a consolidated approach by various healthcare professionals, including nursing staff, phlebotomists, pharmacists, toxicologists, nephrologists, and other healthcare providers. Morbidity and mortality can be high if caffeine overdose is not recognized and treated early. The emergency medicine clinician is responsible for stabilizing the patient and coordinating the patient's care in the emergency department. Some of the responsibilities of the emergency clinician include:

  • Ordering drug levels in the blood and or urine.
  • Monitor the patient for signs and symptoms of respiratory depression, cardiac arrhythmias, electrolyte abnormalities, and seizures.
  • Performing various maneuvers to help limit the absorption of the drug in the body.
  • Consulting poison control specialists and pharmacists regarding the use of activated charcoal, benzodiazepines, supplemental potassium, and esmolol.
  • Consulting toxicologists and nephrologists for further management, which may include dialysis.
  • Consulting the intensivist regarding ICU and monitoring while in the hospital.

Patients require continued care from the moment they enter the emergency department until the time of discharge and beyond. If it is determined that the patient intentionally overdosed, a mental healthcare provider should be consulted once the patient has recovered medically.

Outcomes

The outcomes after caffeine toxicity are excellent. Mortality is very rare for patients who seek treatment. Those who do not seek treatment or the treatment is delayed may develop seizures, arrhythmias, or even aspirate vomitus. Over the past decade, less than 36 deaths have been reported. For those who survive, there are typically no residual sequelae.[36]


Details

Editor:

Jeremy Traylor

Updated:

2/6/2025 1:18:27 AM

Looking for an easier read?

Click here for a simplified version

References


[1]

Tran NL, Barraj LM, Bi X, Jack MM. Trends and patterns of caffeine consumption among US teenagers and young adults, NHANES 2003-2012. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2016 Aug:94():227-42. doi: 10.1016/j.fct.2016.06.007. Epub 2016 Jun 8     [PubMed PMID: 27288929]


[2]

Evans J, Richards JR, Battisti AS. Caffeine. StatPearls. 2025 Jan:():     [PubMed PMID: 30137774]


[3]

Nordt SP, Vilke GM, Clark RF, Lee Cantrell F, Chan TC, Galinato M, Nguyen V, Castillo EM. Energy drink use and adverse effects among emergency department patients. Journal of community health. 2012 Oct:37(5):976-81. doi: 10.1007/s10900-012-9549-9. Epub     [PubMed PMID: 22367607]


[4]

Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipolloni L, Aromatario M. Caffeine-Related Deaths: Manner of Deaths and Categories at Risk. Nutrients. 2018 May 14:10(5):. doi: 10.3390/nu10050611. Epub 2018 May 14     [PubMed PMID: 29757951]


[5]

Holmgren P, Nordén-Pettersson L, Ahlner J. Caffeine fatalities--four case reports. Forensic science international. 2004 Jan 6:139(1):71-3     [PubMed PMID: 14687776]

Level 3 (low-level) evidence

[6]

Winek CL, Wahba W, Williams K, Blenko J, Janssen J. Caffeine fatality: a case report. Forensic science international. 1985 Nov-Dec:29(3-4):207-11     [PubMed PMID: 4076952]

Level 3 (low-level) evidence

[7]

Kerrigan S, Lindsey T. Fatal caffeine overdose: two case reports. Forensic science international. 2005 Oct 4:153(1):67-9     [PubMed PMID: 15935584]

Level 3 (low-level) evidence

[8]

Campana C, Griffin PL, Simon EL. Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure. The American journal of emergency medicine. 2014 Jan:32(1):111.e3-4. doi: 10.1016/j.ajem.2013.08.042. Epub 2013 Sep 27     [PubMed PMID: 24079989]


[9]

Bioh G, Gallagher MM, Prasad U. Survival of a highly toxic dose of caffeine. BMJ case reports. 2013 Feb 8:2013():. doi: 10.1136/bcr-2012-007454. Epub 2013 Feb 8     [PubMed PMID: 23396922]

Level 3 (low-level) evidence

[10]

Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell'Erba A, Palmiere C. A case of suicide by ingestion of caffeine. Forensic science, medicine, and pathology. 2014 Sep:10(3):448-51. doi: 10.1007/s12024-014-9571-6. Epub 2014 Apr 27     [PubMed PMID: 24771479]

Level 3 (low-level) evidence

[11]

Forman J, Aizer A, Young CR. Myocardial infarction resulting from caffeine overdose in an anorectic woman. Annals of emergency medicine. 1997 Jan:29(1):178-80     [PubMed PMID: 8998103]


[12]

Bigard AX. [Risks of energy drinks in youths]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 2010 Nov:17(11):1625-31. doi: 10.1016/j.arcped.2010.08.001. Epub     [PubMed PMID: 20926266]


[13]

Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2017 Dec:55(10):1072-1252. doi: 10.1080/15563650.2017.1388087. Epub 2017 Nov 29     [PubMed PMID: 29185815]


[14]

Garriott JC, Simmons LM, Poklis A, Mackell MA. Five cases of fatal overdose from caffeine-containing "look-alike" drugs. Journal of analytical toxicology. 1985 May-Jun:9(3):141-3     [PubMed PMID: 4010239]

Level 3 (low-level) evidence

[15]

Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System® (NPDS) from America's Poison Centers®: 41st Annual Report. Clinical toxicology (Philadelphia, Pa.). 2024 Dec:62(12):793-1027. doi: 10.1080/15563650.2024.2412423. Epub 2024 Dec 17     [PubMed PMID: 39688840]


[16]

Emohare O, Ratnam V. Multiple cardiac arrests following an overdose of caffeine complicated by penetrating trauma. Anaesthesia. 2006 Jan:61(1):54-6     [PubMed PMID: 16409343]


[17]

Holstege CP, Hunter Y, Baer AB, Savory J, Bruns DE, Boyd JC. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. Journal of toxicology. Clinical toxicology. 2003:41(7):1003-7     [PubMed PMID: 14705850]


[18]

Muraro L, Longo L, Geraldini F, Bortot A, Paoli A, Boscolo A. Intralipid in acute caffeine intoxication: a case report. Journal of anesthesia. 2016 Oct:30(5):895-9. doi: 10.1007/s00540-016-2198-x. Epub 2016 Jun 7     [PubMed PMID: 27272169]

Level 3 (low-level) evidence

[19]

Rudolph T, Knudsen K. A case of fatal caffeine poisoning. Acta anaesthesiologica Scandinavica. 2010 Apr:54(4):521-3. doi: 10.1111/j.1399-6576.2009.02201.x. Epub 2010 Jan 21     [PubMed PMID: 20096021]

Level 3 (low-level) evidence

[20]

Holstege A, Kurz M, Weinbeck M, Gerok W. Excretion of caffeine and its primary degradation products into bile. Journal of hepatology. 1993 Jan:17(1):67-73     [PubMed PMID: 8445222]


[21]

Poussel M, Kimmoun A, Levy B, Gambier N, Dudek F, Puskarczyk E, Poussel JF, Chenuel B. Fatal cardiac arrhythmia following voluntary caffeine overdose in an amateur body-builder athlete. International journal of cardiology. 2013 Jul 1:166(3):e41-2. doi: 10.1016/j.ijcard.2013.01.238. Epub 2013 Mar 7     [PubMed PMID: 23465232]


[22]

Wilson RE, Kado HS, Samson R, Miller AB. A case of caffeine-induced coronary artery vasospasm of a 17-year-old male. Cardiovascular toxicology. 2012 Jun:12(2):175-9. doi: 10.1007/s12012-011-9152-9. Epub     [PubMed PMID: 22231478]

Level 3 (low-level) evidence

[23]

Liao AM, Pan W, Benson JC, Wong AD, Rose BJ, Caltagirone GT. A Simple Colorimetric System for Detecting Target Antigens by a Three-Stage Signal Transformation-Amplification Strategy. Biochemistry. 2018 Aug 28:57(34):5117-5126. doi: 10.1021/acs.biochem.8b00523. Epub 2018 Aug 13     [PubMed PMID: 30064210]


[24]

Routh JI, Shane NA, Arredondo EG, Paul WD. Determination of caffeine in serum and urine. Clinical chemistry. 1969 Aug:15(8):661-8     [PubMed PMID: 5808449]


[25]

Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. The American journal of forensic medicine and pathology. 2013 Dec:34(4):321-4. doi: 10.1097/PAF.0000000000000058. Epub     [PubMed PMID: 24196726]

Level 3 (low-level) evidence

[26]

Kapur R, Smith MD. Treatment of cardiovascular collapse from caffeine overdose with lidocaine, phenylephrine, and hemodialysis. The American journal of emergency medicine. 2009 Feb:27(2):253.e3-6. doi: 10.1016/j.ajem.2008.06.028. Epub     [PubMed PMID: 19371553]


[27]

Li SF,Edwards L,Nguyen V, Treatment of caffeine toxicity with metoprolol. The American journal of emergency medicine. 2019 Mar;     [PubMed PMID: 30514596]


[28]

Cabalag MS, Taylor DM, Knott JC, Buntine P, Smit D, Meyer A. Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2010 Jan:17(1):44-9. doi: 10.1111/j.1553-2712.2009.00616.x. Epub 2009 Dec 9     [PubMed PMID: 20003123]


[29]

Blake KV, Massey KL, Hendeles L, Nickerson D, Neims A. Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice. Annals of emergency medicine. 1988 Oct:17(10):1024-8     [PubMed PMID: 3177989]


[30]

Ishigaki S, Fukasawa H, Kinoshita-Katahashi N, Yasuda H, Kumagai H, Furuya R. Caffeine intoxication successfully treated by hemoperfusion and hemodialysis. Internal medicine (Tokyo, Japan). 2014:53(23):2745-7     [PubMed PMID: 25447662]


[31]

Schmidt M, Farna H, Kurcova I, Zakharov S, Fric M, Waldauf P, Ilgova Z, Pazout J, Pachl J, Duska F. Succesfull treatment of supralethal caffeine overdose with a combination of lipid infusion and dialysis. The American journal of emergency medicine. 2015 May:33(5):738.e5-7. doi: 10.1016/j.ajem.2014.11.002. Epub 2014 Nov 8     [PubMed PMID: 25530192]


[32]

Kohara S, Kamijo Y, Kyan R, Yoshizawa T, Takahashi T, Shin K, Hasegawa E. Severe caffeine poisoning with mexiletine successfully treated by extracorporeal methods. The American journal of emergency medicine. 2024 Dec:86():190.e5-190.e7. doi: 10.1016/j.ajem.2024.09.034. Epub 2024 Sep 26     [PubMed PMID: 39343625]


[33]

Kato Y, Kuriyama A, Hata R, Ikegami T. Extracorporeal Membrane Oxygenation for Hypokalemia and Refractory Ventricular Fibrillation Associated with Caffeine Intoxication. The Journal of emergency medicine. 2020 Jan:58(1):59-62. doi: 10.1016/j.jemermed.2019.09.023. Epub 2019 Nov 15     [PubMed PMID: 31740156]


[34]

Voskoboinik A, Kalman JM, Kistler PM. Caffeine and Arrhythmias: Time to Grind the Data. JACC. Clinical electrophysiology. 2018 Apr:4(4):425-432. doi: 10.1016/j.jacep.2018.01.012. Epub     [PubMed PMID: 30067480]


[35]

Ghannoum M, Wiegand TJ, Liu KD, Calello DP, Godin M, Lavergne V, Gosselin S, Nolin TD, Hoffman RS, EXTRIP workgroup. Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clinical toxicology (Philadelphia, Pa.). 2015 May:53(4):215-29. doi: 10.3109/15563650.2015.1014907. Epub 2015 Feb 26     [PubMed PMID: 25715736]

Level 1 (high-level) evidence

[36]

Seifert SM, Seifert SA, Schaechter JL, Bronstein AC, Benson BE, Hershorin ER, Arheart KL, Franco VI, Lipshultz SE. An analysis of energy-drink toxicity in the National Poison Data System. Clinical toxicology (Philadelphia, Pa.). 2013 Aug:51(7):566-74. doi: 10.3109/15563650.2013.820310. Epub     [PubMed PMID: 23879181]